BATON ROUGE, Louisiana (November 2, 2009) - Amedisys, Inc. (NASDAQ: "AMED" or the “Company”), one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation’s preeminent health care consulting firms, to provide an independent analysis of the Company’s procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies. Marwood conducted a review of academic research, over 11,000 pages of Company specific documents, interviews with 18 members of Company leadership, and interviews with a cross section of other home health providers from across the nation, and utilized its home health industry, legislative and regulatory knowledge to measure industry standards, best practices and leading practices to evaluate the Amedisys model and infrastructure. The results showed that Amedisys ranked highest compared to other publicly traded home health companies in terms of quality improvement and compliance processes. Among their findings, Marwood stated “Amedisys also employs best practices in the areas of field clinician coding and accuracy, oversight and management infrastructure, corporate compliance, and care coordination technology”. They further state, “Based on our Quality and Compliance Process Scorecard and information collected during our review of Company documentation and onsite interviews, Marwood believes that, overall, Amedisys has implemented compliance and quality improvement processes that meet and/or exceed the industry average”.

The entire report has been posted to our website at www.amedisys.com.

“We are pleased with the results that Marwood found in their review of our Company,” stated William F. Borne, Chief Executive Officer. “We operate our Company with a view toward providing clinical excellence for our patients while maintaining effective compliance and controls, and these findings evidence our leadership in these and other measures.”

Marwood Group Advisory, LLC and its affiliated companies (Member FINRA and SIPC) is a nationally recognized healthcare advisory and financial services firm headquartered in New York City with additional offices in Washington DC and London. Marwood has over 90 employees including former senior White House staff, federal agency leaders (including CMS, FDA, HHS and AHRQ) and congressional committee staff members as well as former senior healthcare operators from health plans and hospitals, former employees of state agencies, and former management consultants who monitor and analyze issues related to healthcare. Marwood provides specialized analysis for corporations, financial sponsors and other investors looking to evaluate the regulatory and reimbursement framework and risks associated with making direct investments in healthcare services, life sciences, and devices.

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the NASDAQ Global Select Market under the symbol “AMED”.

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe”, “estimate”, “project”, “expect”, “anticipate” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Many of the factors that could cause or contribute to such differences are described in the Company’s periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management’s control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).

Additional information on the Company can be found at: www.amedisys.com